Univariate analysis | Multivariable analysis for no. of comorbid diseases | Multivariable analysis for no. of comorbidity groups | |||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | p | OR | 95% CI | p | OR | 95% CI | p | |
Entire cohort* | |||||||||
No. of comorbid diseases (range, 0–12) | |||||||||
0 | Ref | < 0.001 | Ref | 0.019 | |||||
1 or 2 | 1.35 | (1.11 to − 1.65) | 1.24 | (1.01 to − 1.53) | |||||
3 or 4 | 1.54 | (1.25 to − 1.89) | 1.35 | (1.09 to − 1.68) | |||||
≥ 5 | 1.87 | (1.50 to − 2.32) | 1.40 | (1.12 to − 1.77) | |||||
No. of comorbidity groups (range, 0–5)*** | |||||||||
0 | Ref | < 0.001 | Ref | 0.001 | |||||
1 or 2 | 1.34 | (1.10 to − 1.62) | 1.22 | (1.00 to − 1.49) | |||||
3 or 4 | 1.70 | (1.39 to − 2.08) | 1.44 | (1.16 to − 1.77) | |||||
5 | 3.26 | (1.77 to − 5.99) | 2.20 | (1.16 to − 4.18) | |||||
Health-screening cohort** | |||||||||
No. of comorbid diseases (range, 0–12) | |||||||||
0 | Ref | 0.004 | Ref | 0.002 | |||||
1 or 2 | 1.59 | (1.09 to − 2.31) | 1.63 | (1.22 to − 2.17) | |||||
3 or 4 | 1.82 | (1.24 to − 2.67) | 1.77 | (1.31 to − 2.38) | |||||
≥ 5 | 2.04 | (1.36 to − 3.07) | 1.78 | (1.28 to − 2.46) | |||||
No. of comorbidity groups (range, 0–5)*** | |||||||||
0 | Ref | < 0.001 | Ref | 0.001 | |||||
1 or 2 | 1.63 | (1.13 to − 2.36) | 1.68 | (1.26 to − 2.23) | |||||
3 or 4 | 1.96 | (1.34 to − 2.87) | 1.81 | (1.35 to − 2.44) | |||||
5 | 5.59 | (2.08 to − 14.98) | 2.23 | (1.01 to − 4.93) |